| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |